Cornerstone Therapeutics' IPO

Cornerstone Therapeutics raised a round of funding on May 27, 2004. Investors include Public.

Cornerstone Therapeutics (NASDAQ: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Key ele…

Articles about Cornerstone Therapeutics' IPO: